Genetic and Anthropometric Interactions: The Role of Waist-to-Hip Ratio in Modulating LDL-C Levels in the Mexican Population

Haibin Max^*
*Correspondence: Haibin Max, Department of Infectious Disease and Global Health, Tufts University, North Grafton, USA, Email:

Introduction

The relationship between genetic factors, anthropometric measurements, and lipid profiles has garnered significant attention in recent years, particularly regarding cardiovascular health. Low-density lipoprotein cholesterol (LDL-C) is a crucial biomarker in assessing cardiovascular risk. This commentary explores the interplay between genetic predispositions, anthropometric factors—specifically waist-to-hip ratio (WHR)—and LDL-C levels in the Mexican population. Understanding these interactions is essential for developing targeted interventions and personalized treatment strategies for managing dyslipidemia and reducing cardiovascular disease risk. Cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, with dyslipidemia—characterized by abnormal lipid levels—playing a significant role in their pathogenesis. Among the various lipoproteins, lowdensity lipoprotein cholesterol is often termed "bad cholesterol" due to its association with atherosclerosis and cardiovascular events. Identifying the factors that influence LDL-C levels is crucial for understanding and mitigating cardiovascular risk. The Mexican population presents a unique context for studying the genetic and anthropometric determinants of LDL-C levels. This population exhibits a high prevalence of metabolic syndrome, diabetes, and obesity, which are closely linked to dyslipidemia. Anthropometric measures, particularly waist-to-hip ratio (WHR), provide insight into body fat distribution and its implications for health. WHR, a measure of central obesity, has been shown to correlate with various metabolic disorders, including dyslipidemia. This commentary aims to examine the intricate relationship between genetic predispositions, WHR, and LDL-C levels in the Mexican population. By exploring this interplay, we can identify potential pathways for intervention and enhance our understanding of the factors contributing to cardiovascular risk [1].

Description

Low-density lipoprotein is a type of lipoprotein that transports cholesterol and triglycerides in the blood. While cholesterol is essential for various physiological processes, elevated levels of LDL-C can lead to the accumulation of cholesterol in the arterial walls, promoting atherosclerosis. The following factors influence LDL-C levels: Genetic predispositions significantly influence lipid metabolism, including LDL-C levels. Variations in genes related to lipid transport, metabolism, and receptor activity can affect LDL-C concentrations. For example, mutations in the LDL receptor gene can lead to familial hypercholesterolemia, a genetic condition characterized by markedly elevated LDL-C levels. Diet plays a critical role in modulating lipid profiles. High intake of saturated fats and trans fats has been associated with increased LDL-C levels, while diets rich in unsaturated fats, fiber, and plant sterols can help lower LDL-C. Physical activity, smoking, and alcohol consumption can also affect LDL-C levels. Regular physical activity is associated with improved lipid profiles, while smoking has detrimental effects. Body mass index (BMI) and WHR are important indicators of body composition and fat distribution. Central obesity, as indicated by a high WHR, is particularly concerning as it is associated with insulin resistance and dyslipidemia [2].

Waist-to-hip ratio is a widely used anthropometric measure that assesses body fat distribution. It is calculated by dividing the circumference of the waist by the circumference of the hips. WHR provides insight into the distribution of visceral fat, which is associated with a higher risk of metabolic disorders compared to subcutaneous fat. Research has shown that WHR is a more reliable predictor of cardiovascular risk than BMI alone, especially in populations with a higher prevalence of abdominal obesity. Central obesity, as indicated by a high WHR, is linked to several metabolic abnormalities. Abdominal fat is metabolically active and can lead to insulin resistance, a precursor to type 2 diabetes and associated dyslipidemia. Visceral fat produces pro-inflammatory cytokines that can contribute to endothelial dysfunction and atherosclerosis. A high WHR is associated with increased LDL-C levels and decreased high-density lipoprotein cholesterol (HDL-C) levels, leading to a higher risk of CVD. The Mexican population is characterized by unique dietary and lifestyle factors that contribute to body composition and fat distribution. The prevalence of obesity and metabolic syndrome is high, making WHR an essential measure for assessing cardiovascular risk. Studies have shown that individuals with a high WHR in Mexico are more likely to exhibit dyslipidemic profiles, emphasizing the need for targeted interventions [3].

The LDLR gene encodes the LDL receptor, which is responsible for clearing LDL from the bloodstream. Variants in this gene can lead to familial hypercholesterolemia, resulting in elevated LDL-C levels. Apolipoprotein B is a primary protein component of LDL. Genetic variations in the ApoB gene can affect LDL metabolism and contribute to dyslipidemia. The PCSK9 gene encodes a protein that regulates LDL receptor levels. Mutations in this gene can lead to increased LDL-C levels by reducing the number of LDL receptors available to clear LDL from the blood. The interplay between genetic factors and environmental influences is crucial for understanding LDL-C levels. In the Mexican population, the prevalence of specific genetic variants may interact with dietary and lifestyle factors, exacerbating dyslipidemia. For example, individuals with genetic predispositions to high LDL-C may be particularly susceptible to the adverse effects of a high-fat diet or low physical activity levels. Conversely, those without such genetic predispositions may not experience significant increases in LDL-C even with similar lifestyle factors [4].

Individuals with genetic variants associated with high LDL-C may experience more pronounced effects on their lipid profiles if they also have central obesity. The combination of genetic predisposition and poor fat distribution could lead to significantly higher LDL-C levels. The presence of visceral fat can influence metabolic pathways related to lipid metabolism. For instance, the inflammatory mediators released by visceral adipose tissue can affect hepatic lipid metabolism, exacerbating the effects of genetic factors. The interactions between WHR, genetic predispositions, and LDL-C levels may vary across populations. In the Mexican population, traditional diets may influence the degree to which genetic factors affect LDL-C levels. For example, a diet high in refined carbohydrates and saturated fats may exacerbate the effects of genetic variants associated with dyslipidemia, particularly in individuals with central obesity. Sedentary lifestyles prevalent in certain segments of the Mexican population can further heighten the risk of dyslipidemia among genetically predisposed individuals.

Understanding the interplay between genetic factors, WHR, and LDL-C levels in the Mexican population has important implications for public health and clinical practice. Recognizing the genetic and anthropometric risk factors for dyslipidemia can inform personalized dietary recommendations. Individuals with high WHR and genetic predispositions may benefit from specific dietary modifications aimed at reducing LDL-C levels. Encouraging regular physical activity is crucial for individuals with high WHR and genetic risk factors. Exercise can help reduce visceral fat and improve lipid profiles, potentially mitigating genetic risks. Routine Assessments: Incorporating WHR measurements into routine clinical assessments can help identify individuals at risk for dyslipidemia and cardiovascular diseases. This approach allows for early interventions. Genetic screening for known variants associated with lipid metabolism can help identify individuals who may be more susceptible to dyslipidemia, particularly when combined with anthropometric assessments like WHR. Public health initiatives should focus on educating communities about the risks associated with high WHR and genetic predispositions to dyslipidemia. Awareness campaigns can encourage healthier lifestyle choices. Policymakers can play a role in creating environments that promote physical activity and access to healthy foods, particularly in areas with high obesity rates [5].

Conclusion

The interplay between genetic factors, waist-to-hip ratio, and LDL-C levels is a complex and multifaceted issue, particularly within the context of the Mexican population. Understanding this interplay is essential for developing effective strategies to address dyslipidemia and reduce cardiovascular disease risk. By recognizing the role of anthropometric measures like WHR alongside genetic predispositions, healthcare professionals can implement targeted interventions, improve screening practices, and promote healthier lifestyles. Ultimately, addressing these factors

Acknowledgement

None.

Conflict of Interest

None.

References

1. Tham, Kwang Wei, Rohana Abdul Ghani, Sioksoan C. Cua and Chaicharn Deerochanawong et al. "Obesity in South and Southeast Asia—A new consensus on care and management." Obes Rev 24 (2023): e13520.

Google Scholar, Crossref, Indexed at

2. Socol, Claudia Terezia, Alexandra Chira, Maria Antonia Martinez-Sanchez and Maria Angeles Nuñez-Sanchez, et al. "Leptin signaling in obesity and colorectal cancer." Int. J Mol Sci 23 (2022): 4713.

Google Scholar, Crossref, Indexed at

3. Hancková, Miriam and Tatiana Betakova. "Pandemics of the 21st century: The risk factor for obese people." Viruses 14 (2021): 25.

Google Scholar, Crossref, Indexed at

4. Aceves‐Martins, Magaly, Lizet López‐Cruz, Marcela García‐Botello and Naara L. Godina‐Flores et al. "Cultural factors related to childhood and adolescent obesity in Mexico: A systematic review of qualitative studies." Obes Rev 23 (2022): e13461.

Google Scholar, Crossref, Indexed at

5. Kinlen, David, Declan Cody and Donal O’Shea. "Complications of obesity." QJM 111 (2018): 437-443.

Google Scholar, Crossref, Indexed at